Literature DB >> 2142945

Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli.

M Fountoulakis1, J F Juranville, D Stüber, E K Weibel, G Garotta.   

Abstract

We purified and characterized a soluble human interferon gamma receptor expressed in Escherichia coli. The soluble receptor comprises the amino acids 15-246 of the encoded protein (Aguet, M., Dembic, Z., and Merlin, G. (1988) Cell 55, 273-280) and was purified from large scale fermentations through four chromatographic steps with an overall recovery of 28%. The refolded soluble receptor shows some heterogeneity on nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis, where it appears as the major band of 27 kDa molecular mass, accompanied by a few minor bands with molecular masses between 26 and 30 kDa. On reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis it appears as a homogeneous protein of 32 kDa molecular mass. The soluble interferon gamma receptor is an active and stable protein and is recognized by specific antibodies raised against the native receptor. When nonreduced it has the capacity to specifically bind interferon gamma and to compete for the binding of interferon gamma to the cell surface receptor. The observed heterogeneity of the soluble interferon gamma receptor under nonreducing electrophoretic conditions is probably due to different conformational forms resulting from the formation of non-native intramolecular disulfide bonds among the 8 cysteine residues present in the soluble interferon gamma receptor molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142945

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells.

Authors:  Alevtina D Domashenko; Gwenn Danet-Desnoyers; Alissa Aron; Martin P Carroll; Stephen G Emerson
Journal:  Blood       Date:  2010-07-08       Impact factor: 22.113

Review 2.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

3.  Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.

Authors:  M Haak-Frendscho; S A Marsters; S M Chamow; D H Peers; N J Simpson; A Ashkenazi
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

Review 4.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

5.  Functional characterization of a hybrid human-mouse interferon gamma receptor: evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer.

Authors:  S Hemmi; G Merlin; M Aguet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  Structural analysis and localization of the carbohydrate moieties of a soluble human interferon gamma receptor produced in baculovirus-infected insect cells.

Authors:  M Manneberg; A Friedlein; H Kurth; H W Lahm; M Fountoulakis
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

7.  Osmotic-driven release kinetics of bioactive therapeutic proteins from a biodegradable elastomer are linear, constant, similar, and adjustable.

Authors:  Frank Gu; Ronald Neufeld; Brian Amsden
Journal:  Pharm Res       Date:  2006-03-24       Impact factor: 4.200

8.  Human γS-Crystallin-Copper Binding Helps Buffer against Aggregation Caused by Oxidative Damage.

Authors:  Kyle W Roskamp; Sana Azim; Günther Kassier; Brenna Norton-Baker; Marc A Sprague-Piercy; R J Dwyane Miller; Rachel W Martin
Journal:  Biochemistry       Date:  2020-06-12       Impact factor: 3.162

9.  The extracellular domain of the human interferon gamma receptor interacts with a species-specific signal transducer.

Authors:  V C Gibbs; S R Williams; P W Gray; R D Schreiber; D Pennica; G Rice; D V Goeddel
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  Construction, purification, and characterization of a chimeric TH1 antagonist.

Authors:  Iraldo Bello-Rivero; Yeny Torrez-Ruiz; Elizabeth Blanco-Garcés; Giselle Pentón-Rol; Osmani Fernández-Batista; Luís Javier-González; Haydee Gerónimo-Perez; Pedro López-Saura
Journal:  BMC Biotechnol       Date:  2006-05-22       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.